Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma
by on Thursday, June 7th, 2012 | No Comments
Condition: Advanced Melanoma
Intervention: Drug: dacarbazine (DTIC), Trofosfamide, Etoricoxib, Pioglitazone, Temsirolimus
Sponsors: University of Regensburg; University of Regensburg; ClinAssess GmbH
Recruiting – verified June 2012
Go here to read the rest: Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma